跳到正文
原文
NIH· @NIH · X·· 20 天前精选AI 评分40
AI 导读

NIH通过Complement-ARIE研究计划投入1.5亿美元,资助多个新技术中心开发用于科学与监管需求的非动物测试方法。其中一个由美国国家转化科学促进中心和美国国家环境健康科学研究所共同领导的中心,将聚焦硬皮病和Hermansky-Pudlak综合征肺纤维化等纤维化疾病。

推荐理由

NIH通过Complement-ARIE项目资助非动物测试技术中心,读者可了解监管科学替代方法在纤维化疾病领域的布局。

正文

DYK: NIH’s $150 million investment through the Complement Animal Research In Experimentation (Complement-ARIE) Research Program has helped fund several new tech centers that are developing non-animal testing methods for use in areas of scientific and regulatory need.

One center—co-led by the National Center for Advancing Translational Sciences and the National Institute of Environmental Health Sciences—will focus on fibrotic diseases like scleroderma and Hermansky-Pudlak syndrome pulmonary fibrosis.

Read more ➡️ https://bit.ly/4zb2lwt

来源:NIH · x.com